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Abstract There are studies about health-related quality of
life (HRQoL) in patients with rheumatoid arthritis (RA),
but few studies prospectively assessed HRQoL. The main
purpose of this study was to analyze HRQoL in patients
hospitalized due to RA exacerbation and observed over a
planned 2-year follow-up in an outpatient setting. The
study involved 42 women and 9 men, at mean age of
62.5 years (SD § 12.6). The mean duration of the study
was 22–23 months. The HRQoL analysis was performed
using the SF-36 survey. At the beginning of the study, basic
data on age, sex, selected biochemical (ESR, CRP, GFR,
hemoglobin, plasma albumin, plasma protein), and clinical
parameters (the duration of RA, VAS, DAS28, BMI, the
presence of cardiovascular disease, diabetes, osteoporosis,
osteoporotic fractures, osteoarthritis, neoplasm) were col-
lected. Questionnaires were completed at the beginning and
end of the study. Statistically signiWcant reductions in
HRQoL scores were observed in social functioning (SF;
0.42 vs 0.32, P < 0.05), whereas role-emotional health (RE;
0.48 vs 0.59, P < 0.05) and mental health (MH; 0.47 vs
0.54, P < 0.05) scores were increased. A decrease in the SF
was positively correlated with the lack of osteoporosis at
baseline (r = 0.35, P > 0.02). An increase in the MH was
inversely correlated with BMI (r = ¡0.31, P < 0.05), and
the level of hemoglobin (r = ¡0.32, P < 0.028) and posi-
tively correlated with the presence of osteoarthritis at base-
line (r = 0.29, P < 0.05). In RA patients, dimensions of
HRQoL as SF, RE, and MH could change within 2 years
and these changes could be related to comorbidities.
Although preliminary Wndings are promising, further stud-
ies are needed.
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Introduction and purpose
Rheumatoid arthritis (RA) is a systemic, autoimmune,
inXammatory disease of unknown etiology [1]. RA is usu-
ally characterized as a progressive disease, leading to joint
destruction, physical activity limitation, disability, and pre-
mature death. Other complications of the disease are a
worsening of social functioning, emotional health, and the
quality of life. Additional relevant factors connected with
treatment are the costs of health care of RA patients and the
costs of complications due to RA treatment. The need for a
comprehensive approach to the evaluation of disease pro-
gression resulted in an increased interest in an objective
assessment of disease progression and patient’s subjective
well-being. The attention to the health-related quality of life
is a consequence of a comprehensive approach to treating
patients with RA. The patients’ quality of life may be
aVected by many factors in multiple dimensions. In the case
of patients with RA, additional factors that may modify
HRQoL are disability, pain, fatigue, depression, comorbidi-
ties and others.
HRQoL estimation with use of questionnaires can play
important role in treatment of RA. In literature, it was
reported that a RAPID3 or a RADAI5 score could serve the
same function as ESR and CRP for rheumatologists and a
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Patient questionnaire scores for physical function are the
most signiWcant predictors of work disability and premature
mortality, somewhat greater than joint count measures, and
far more signiWcant than radiographic and any laboratory
data [3]. Additionally, it was reported that patient question-
naire scores indicating poor functional status predicted sur-
vival of less than 50 % of RA patients over the next 5 years
[4]. The questionnaires most commonly used in assessing
HRQoL in RA patients are the following: AIMS (Arthritis
Impact Measurement Scales) [5], RAQoL (Rheumatoid
Arthritis Quality of Life instrument) [6], HAQ (Health
Assessment Questionnaire) [7], and SF-36 (36-item short-
form health survey) [8].
There are studies analyzing HRQoL with SF-36 survey
among patients with RA. SF-36 was described as reliable,
valid, and able to measure the clinically important aspects
of health status in British patients with RA [9]. The Chinese
version of the SF-36 showed reasonable reliability, crite-
rion validity, and responsiveness with limitations in certain
subscales in RA patients [10]. Small improvements in
HRQoL measured with SF-36 survey were seen in cross-
sectional and longitudinal studies in RA patients from
Sweden, and these improvements were exclusively attribut-
able to treatment with biologics [11]. In one systematic
review of the literature and meta-analysis assessing the
eVect of biotherapies versus placebo on fatigue, in combi-
nation with DMARDs with use of (FACIT-F) or short-form
36 (SF-36) vitality scores at baseline and at week 24, it was
reported that the impact of biotherapies on fatigue in RA
was small [12]. In study focused on HRQoL in patients
with severe osteoarthritis or rheumatoid arthritis, an arthri-
tis-speciWc health index (ASHI) was used [13]. The patterns
of correlations between SF-36 scales and the ASHI were
very similar across developmental and cross-validation
samples. In conclusion, it was said that SF-36 survey can be
useful in studies of rheumatoid arthritis. Data from 7 dou-
ble-blind, randomized controlled trials that examined the
eVectiveness of one or more interventions in RA and the
primary outcome measures evaluating data from SF-36 sur-
veys showed that SF-36 deserves serious consideration for
inclusion in the core set of outcomes in RA trials [14].
The primary aim of this study was to analyze changes in
SF-36 scale scores over a 2-year period. A secondary aim
was to analyze the correlation between the observed
changes in HRQoL scale scores and the demographic, bio-
chemical, and clinical parameters. Another additional aim
was psychometric evaluation of the HRQoL instrument
used in this study in terms of its accuracy and reliability. To
assess HRQoL, we used SF-36 questionnaires completed
by the patients. Questionnaires should be evaluated as to
their psychometric reliability, accuracy, and the ability to
capture changes in the evaluated parameters in a given
period of time [15]. This evaluation was done in this study.
Standardization of the obtained results, that is, presenting
them within the framework of the adopted scale, usually
requires their conversion into a 0–1 or 0–100 % format and
allows a comparison of the results not only in the study
group but also between diVerent groups of patients. In this
paper, the obtained results were presented in the 0–1 range.
The psychometric assessment of SF-36 was calculated
using Cronbach’s alpha reliability coeYcients and parame-
ters of convergent validity and discriminant validity.
Materials and methods
HRQoL was studied in patients of the Rheumatology and
Internal Medicine Department of the Central Clinical Hos-
pital of Ministry of Internal AVairs and Administration in
Warsaw. In the study, HRQoL analysis was based on data
obtained from 51 patients: 42 women and 9 men. In the
study group, 35 patients (pts) had cardiovascular disease, 6
pts had diabetes, 20 pts had osteoporosis, 44 pts had osteo-
arthritis, 8 were treated because of neoplastic disease within
the last 5 years, and 10 pts had previous osteoporotic frac-
tures. RA patients were treated with a standard treatment
regimen. Median RA duration was 10 years, 42 pts had ero-
sive disease, 35 pts were treated with MTX (25 mono-
therapy, 10 in combination with other DMARDs), 9 pts
were treated with anti-TNF, 2 pts with tocilizumab, 1 pts
with rituksymab; 41 pts took low dose of oral steroids.
Licenses for the use of SF-36 were achieved (license num-
bers CT113991/OP000073 and CT134122/OP013928).
This study was a continuation of previous work focused of
HRQoL in RA patients [16]. Socio-demographic character-
istics, medical records, and HRQoL data collected at base-
line were presented in the previous study. The next
completion of the HRQoL questionnaire was to take place
after 2 years. In this study, the second completion of the
HRQoL questionnaire was conducted after a mean period
of 22–23 months, in person (preferred option) or via tele-
phone. The baseline data collection was done between
April 2009 and December 2009, and the second HRQoL
assessment was done between April 2011 and June 2011.
The HRQoL scales were measured according to recommen-
dations by the authors of the SF-36 survey. The data on
HRQoL were collected using version 2 of the SF-36 sur-
vey, with the text translated into Polish provided by the
Licensor of the SF-36 survey. The collected data were ana-
lyzed using Statistica program, ver. 6. Statistical signiW-
cance of changes in SF-36 scale scores was tested using
nonparametric statistics (Wilcoxon’s tests) for paired fac-
tors. The level of statistical signiWcance was set at P < 0.05.
The HRQoL measurement tool—the SF-36 survey includes
36 items (questions) forming 8 scales. Abbreviations of123
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Role-Physical, BP—Bodily Pain, GH—General Health,
VT—Vitality; SF—Social Functioning, RE—Role-Emo-
tional, MH—Mental Health, NS—no statistical signiW-
cance.
Results
This study analyzed changes in SF-36 scale scores. The
study group consisted of 51 patients, 42 women and 9 men.
The average age of all patients at baseline was 62.5 years
(SD §12.6 years), maximum 86 years, minimum 29 years,
median 63 years. After 22–23 months, HRQoL data were
collected from 47 patients; 3 people died during the study
and one patient’s clinical condition did not allow for
HRQoL data collection. Table 1 shows the results of the
SF-36 scales measurement in a standardized form. The Wrst
measurement (meas. I) refers to the HRQoL scales assessed
at baseline, the second measurement (meas. II) refers to the
HRQoL scales after the follow-up period. Standardization
of the HRQoL scales involved presenting the individual
scores in the form of values falling within an accepted
range, either in the percentage form, or in the range from 0
to 1, with low values indicating poor HRQoL in the given
dimension, or worse well-being of the patient. Conversely,
high values indicate improved HRQoL, or better condition
of the patient. The values of all HRQoL scale scores were
below the half of their corresponding maximum values. In
general, patients well-tolerated the study and provided
prompt responses during their SF-36 survey completion.
The psychometric value of the SF-36 questionnaire was
evaluated with respect to its reliability and validity. The
reliability of the questionnaire was assessed using an inter-
nal consistency test (Cronbach’s alpha) [17]. Calculated in
the program Statistica, Cronbach’s alpha values for individ-
ual scales were higher than 0.7, with the PF scale value
above 0.9. It has been pointed out in literature that an
instrument meeting these criteria is of good reliability [18].
In this study, Cronbach’s alpha values indicate a good reli-
ability of the SF-36 form. The validity of the questionnaire
was analyzed using the parameters of convergent validity
and discriminant validity. The psychometric assessment
parameters of data collected during the second measure-
ment (presented in Table 2) show good results for the indi-
vidual scales, despite the fact that values of 100 % were not
achieved in all scales. The results show good validity of the
SF-36 questionnaire.
In the analyzed period of time, a statistically signiWcant
reduction in HRQoL scale scores was observed in the SF
scale (0.42 vs 0.32, P < 0.05). A statistically signiWcant
improvement in HRQoL scores was observed in the RE
scale (0.48 vs 0.59, P < 0.05) and MH scale (0.47 vs 0.54,
P < 0.05). There were no signiWcant changes in other
dimensions of HRQoL (PF, RP, BP, GH, VT). After
2 years, HRQoL scale scores showed statistically signiW-
cant changes. Moreover, statistically signiWcant correla-
tions with selected biochemical and clinical variables were
recorded. A decrease in SF scale score was correlated with
the lack of osteoporosis at baseline (r = 0.35, P < 0.02). An
improvement in MH scale score was inversely correlated
with body mass index (BMI) values (r = ¡0.31, P < 0.05)
Table 1 Statistical characteristics of SF-36 scales
SF-36 
scales
Mean value Minimum value Maximum value Standard deviation Median
Meas. I Meas. II Statistical 
signiWcance
Meas. I Meas. II I Meas. II Meas. I Meas. II Meas. I Meas. II Meas.
PF 0.43 0.41 NS 0.0 0.0 1.0 0.85 0.26 0.19 0.40 0.40
RP 0.42 0.39 NS 0.0 0.0 0.87 0.75 0.16 0.17 0.44 0.38
BP 0.32 0.39 NS 0.0 0.0 1.0 0.84 0.18 0.20 0.32 0.41
GH 0.29 0.30 NS 0.0 0.0 0.62 0.77 0.15 0.17 0.30 0.25
VT 0.32 0.32 NS 0.15 0.0 0.8 0.63 0.12 0.13 0.30 0.31
SF 0.42 0.32 P < 0.05 0.0 0.0 1.0 0.75 0.26 0.28 0.50 0.25
RE 0.48 0.59 P < 0.05 0.0 0.0 1.0 0.92 0.24 0.19 0.50 0.67
MH 0.47 0.54 P < 0.05 0.24 0.0 0.68 0.75 0.10 0.13 0.48 0.55









PF 0.90 100 96
RP 0.85 100 89
BP 0.82 100 79
GH 0.79 100 89
VT 0.72 100 93
SF 0.91 100 100
RE 0.79 100 100
MH 0.76 80 80123
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positively correlated with the presence of osteoarthritis at
baseline (r = 0.29, P < 0.05).
Discussion
A growing interest in the health-related quality of life in
chronic diseases is illustrated by the number of studies
available in the medical literature. The number of these
publications has grown signiWcantly in recent years.
HRQoL in medicine was adopted to describe the eVect of
diseases and its treatment on physical, psychological, and
social aspects of patients’ well-being. HRQoL is one of the
components of quality of life, which can be aVected by
many factors, not only medical health, but also the cultural,
socio-economic, and other factors as well as other areas of
human activity. When we estimate the inXuence of numer-
ous factors on the quality of life, we examine the inXuence
of variables on patients’ subjective feelings and try to
describe HRQoL objectively, and even using numbers. The
subjective nature of HRQoL makes it diYcult to analyze
HRQoL and obtained data only approximately characterize
HRQOL. An analysis of HRQOL may be helpful in build-
ing a comprehensive therapeutic strategy targeted to
achieve the best possible physical, mental, and social well-
being of the patient. In patients with rheumatoid arthritis,
an assessment of HRQoL is the most important element in
building the therapeutic strategy. This results from the fact
that RA is often progressive in nature, leading to disability,
as well as aVecting life expectancy.
Many questionnaires, used to assess HRQOL, have been
presented as reliable and studied in patient populations in
diVerent countries or diVerent clinical situations [19, 20].
Several studies have indicated that the HRQoL of RA
patients was signiWcantly lower than that in the general
population [21, 22]. It was also observed in Polish patients
[23]. There are questionnaires speciWc to particular diseases
or medical procedures as well as general questionnaires. A
general questionnaire, the SF-36, was selected for this
study because of its brevity, comprehensiveness, a high
standard of integrity, and good reliability and validity
parameters [24, 25]. The rationale behind selecting a gen-
eral questionnaire for the study was the fact that patients
with RA often suVer from other diseases that could hinder
the assessment of HRQoL. In this paper, the SF-36 ques-
tionnaire was well accepted by patients. Reliability coeY-
cients (Cronbach’s alpha) for the diVerent scales were
higher than 0.7 and, in the case of PF, above 0.9. In this
study, accuracy parameters in most cases have reached
100 % in tests of consistency. Consistency tests analyze
what proportion of responses to each question correlates
with the value of the own scale at the level above 0, 4. The
discriminant validity test in most cases yielded values of
80–100 %. A discriminant validity test describes what pro-
portion of SF-36 items correlates higher with its own scale
than with other scales.
The studied group of patients remained under specialist
care during the study. Detailed patient education, system-
atic specialist outpatient care, and a regular use of medica-
tions were all part of a comprehensive approach to
treatment of RA patients. This holistic approach was taken
in order to slow the progression of the disease, to achieve
the maximum reduction of RA-related complications, and
to improve the patients’ functioning in a local community.
In this study, we observed signiWcant changes in HRQoL
scores relating mainly to social activities or emotional and
mental health. These scales seem to be more diYcult to
describe, as opposed to scales related to physical health. In
this study, we expected to see an age-dependent decrease in
physical functioning, as a deterioration in physical function
with age has been reported in literature [26]. In the present
study, there were no signiWcant changes in HRQoL scale
scores relating to physical functioning. This can be
explained by systematic specialist outpatient care, regular
treatment, and patient education. On the other hand, it was
reported that an improvement in the area of emotional well-
being in patients with RA can be related to age [27].
Increase in values of scale describing mental health also
observed in this prospective 2-year follow-up study. These
observations may be helpful in the treatment of patients,
with a special focus on the elderly with RA. It has been
reported in literature that a clinical remission in rheumatoid
arthritis may reduce symptoms of depression and anxiety
and that it independently improves the quality of life [28].
The use of therapies aimed at achieving clinical remission
of RA may result in an improvement in mental, emotional
areas of HRQoL.
In one study on HRQoL with use of SF-36, it was indi-
cated that the appearance of comorbidities may have an
impact on physical health domains, but no signiWcant eVect
on the emotional health [29]. The presence of comorbidities
in patients with RA in the beginning of the study may
explain the lack of signiWcant score changes in the SF-36
scales related to physical functioning.
There have been reports of a relationship between ane-
mia and the well-being of RA patients [30]. In our study,
we showed a statistically signiWcant negative correlation
between hemoglobin levels and changes in mental health
(MH) scores. Baseline hemoglobin levels can be related to
RA progression. It can be assumed that patients with lower
baseline hemoglobin level may have advanced disease pro-
gression, physical activity limitations, and poor well-being.
Improvement in mental health scores in these patients may
be related to specialist outpatient care during the study.
This conclusion is important according to report from other123
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ulation revealed a reduction of ¡0.27 for mental health
measured by standardized diVerence scores (s-scores), indi-
cating a low to moderate disease eVect for mental health
[31]. Mental health is very important factor in RA patients
because depression is related to poor treatment compliance
and increased morbidity and mortality in rheumatic condi-
tions [32]. The presence of a signiWcant negative correla-
tion between the body mass index (BMI) and changes in
mental health scale (MH) scores can be explained in a simi-
lar fashion. These results may require further research. In
this study, the presence of osteoarthritis (OA) at baseline
was signiWcantly positively correlated with changes in MH
scale scores. The additional presence of osteoarthritis indi-
cates worse functioning in RA patients. One trial, compar-
ing the well-being of RA patients with that of OA patients,
showed no signiWcant diVerence between the functioning
and quality of life in the study groups, although the results
suggested a better quality of life in the group of RA patients
[33]. It is possible that the presence of OA and RA may
widely worsen HRQoL at baseline. The comprehensive
treatment and care implemented over 2 years can cause
improvement in all HRQoL scales, but noticeable improve-
ment in HRQoL mental health scale. The lack of osteoporo-
sis at study baseline was signiWcantly positively correlated
with a decrease in the SF scale score. The lack of osteopo-
rosis at baseline might be related to low RA activity, but the
progression of the disease and the inXuence of drugs could
increase the risk of osteoporosis and a deterioration of
HRQoL in the SF scale.
Conclusions
1. The prospective 2-year study on health-related quality
of life (HRQoL) in RA patients under specialist outpa-
tient care showed a statistically signiWcant decrease in
the value of the scale related to social functioning (SF),
increase in the value of the scales related to the role-
emotional problems (RE) and increase in the value of
the scale related to mental health (MH).
2. The prospective 2-year study on health-related quality
of life in patients with RA under specialist outpatient
care showed no statistically signiWcant score changes
in the HRQoL scales related to physical functioning
(PF), role-physical (RP), bodily pain (BP), general
health perception (GH), and vitality (VT).
3. The SF-36 survey was shown to have good psychomet-
ric assessment parameters, indicating its usefulness in
the research on HRQoL in RA patients. In addition, the
SF-36 questionnaire was well accepted by patients.
4. In the present study, some HRQoL scales were signiW-
cantly correlated with selected biochemical and clinical
variables. Deterioration in the social function scale
(SF) score was positively correlated with the lack of
osteoporosis at baseline. An improvement in the mental
health scale (MH) score was inversely correlated with
the values of body mass index and hemoglobin levels
at baseline and positively correlated with the presence
of osteoarthritis at baseline.
5. The study results indicate that particular attention
should be paid to the problem of social and emotional
functioning of RA patients and may be helpful in build-
ing therapeutic strategies and further research on
HRQoL.
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